Eckhard Strauch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eckhard Strauch has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A. Konietzny
Addresses of authors: Robert Koch‐Institut, Nordufer 20, 13353 Berlin, Germany
1 shared publicationAnne Bernhardt
Project Group Biological Safety, Robert Koch Institute, Germany
1 shared publicationB. Appel
Addresses of authors: Robert Koch‐Institut, Nordufer 20, 13353 Berlin, Germany
1 shared publicationBernd Appel
Project Group Biological Safety, Robert Koch Institute, Germany
1 shared publicationC. Damasko
Robert Koch-Institut, Nordufer 20, 13353 Berlin, Germany
1 shared publication- Dominik Schwudke
Division of Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center, Borstel, Germany
1 shared publication
Latest Publications
- 29 September 2005
- Published by Springer Nature in Current Microbiology
- Vol. 51 (5) , 310-316
Transcriptional Activity of the Host-Interaction Locus and a Putative Pilin Gene of Bdellovibrio bacteriovorus in the Predatory Life Cycle
- 29 September 2005
- Published by Springer Nature in Current Microbiology
- Vol. 51 (5) , 310-316
Transcriptional Activity of the Host-Interaction Locus and a Putative Pilin Gene of Bdellovibrio bacteriovorus in the Predatory Life Cycle
- 1 May 2005
- Published by Wiley in Journal of Veterinary Medicine, Series B
- Vol. 52 (4) , 171-179
Studies of the Efficacy of Enterocoliticin, a Phage‐Tail Like Bacteriocin, as Antimicrobial Agent Against Yersinia enterocolitica Serotype O3 in a Cell Culture System and in Mice
The efficacy of enterocoliticin, a phage tail-like bacteriocin, as antimicrobial compound against infections with pathogenic Yersinia enterocolitica serotype O3 strains was assessed. In cell cultures, which were infected with the Y. enterocolitica strains 13 169 or 6471/76, bactericidal activity of enterocoliticin was found for bacteria adhering to the surface of eukaryotic cells, whereas bacteria, which had invaded the eukaryotic cells, were not accessible to the bacteriocin. The interaction of enterocoliticin with Y. enterocolitica was further examined in animals. Female BALB/c mice were experimentally infected with the two Y. enterocolitica strains and enterocoliticin was applied as antimicrobial compound by the oral route. Experimental variations concerning the infectious doses of the Y. enterocolitica strains and the time points of application of the bacteriocin were investigated. The increase of the Yersinia CFU titre in animals was retarded at time points shortly after the application of enterocoliticin indicating that the particles were effective on recently introduced Yersinia. The repeated application of enterocoliticin, however, did not prevent the colonization of the gastrointestinal tract by Yersinia.
- 1 May 2005
- Published by Wiley in Journal of Veterinary Medicine, Series B
- Vol. 52 (4) , 171-179
Studies of the Efficacy of Enterocoliticin, a Phage‐Tail Like Bacteriocin, as Antimicrobial Agent Against Yersinia enterocolitica Serotype O3 in a Cell Culture System and in Mice
The efficacy of enterocoliticin, a phage tail-like bacteriocin, as antimicrobial compound against infections with pathogenic Yersinia enterocolitica serotype O3 strains was assessed. In cell cultures, which were infected with the Y. enterocolitica strains 13 169 or 6471/76, bactericidal activity of enterocoliticin was found for bacteria adhering to the surface of eukaryotic cells, whereas bacteria, which had invaded the eukaryotic cells, were not accessible to the bacteriocin. The interaction of enterocoliticin with Y. enterocolitica was further examined in animals. Female BALB/c mice were experimentally infected with the two Y. enterocolitica strains and enterocoliticin was applied as antimicrobial compound by the oral route. Experimental variations concerning the infectious doses of the Y. enterocolitica strains and the time points of application of the bacteriocin were investigated. The increase of the Yersinia CFU titre in animals was retarded at time points shortly after the application of enterocoliticin indicating that the particles were effective on recently introduced Yersinia. The repeated application of enterocoliticin, however, did not prevent the colonization of the gastrointestinal tract by Yersinia.